Cytomegalovirus Diagnostics Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017 to 2021 and Forecast 2022 to 2028

$ PRICE - $ 3,000.00 – $ 8,900.00

Cytomegalovirus Diagnostics Market by Test (Serology, Cell culture, Antigenemia assay, Polymerase Chain Reaction Amplification, Immunohistochemistry, Nucleic acid sequence-based amplification (NASBA), Hybrid capture assay), by Application (Retinitis, Pneumonia, Gastrointestinal Ulcers, Encephalitis, Others), By End-user (Hospitals, Diagnostic Centers, Others) and Geography

Request Sample

Request Methodology

Request Sample

$ PRICE - $ 3,000.00 – $ 8,900.00

Clear selection

SKU: N/A Categories: Biotechnology, Healthcare

Description
Table Of Content
Company Profile

Report

Description

Cytomegalovirus Diagnostics Market size was valued USD 73.6 million in 2021, growing at a CAGR of 6.1% during the forecast period 2022-28. Cytomegalovirus (CMV) infection is the common herpes virus infection having different symptoms which occurs in all ages of people around the world. Cytomegalovirus (CMV) infection is a communicable and easily prone through the body fluids like urine, saliva, blood, breast milk and semen. The infection may spread fast from urine or saliva from people who are infected with CMV having virus in their bodily fluids. The disease can transmit from pregnant to baby during delivery. Organ transplant and blood transfusion are the other way for the transmission for the disease. Cytomegalovirus diagnostics market is mainly propelling by the rise in the prevalence of CMV infections, growing awareness about herpes disease, initiatives taken by key market players for the diagnosis of CMV infection are propelling the growth of CMV diagnostics market. Moreover, rise in the support of government, and development of healthcare infrastructure are anticipated to propel growth of CMV diagnostics market. Lack of awareness and price sensitivity are the few factors hampering the growth of CMV diagnostics market.

Key Developments:

In Jun 2017, Abbott received U.S. FDA approval for Real-time CMV molecular test, the only cytomegalovirus test which is available commercially which amplifies two selective regions of CMV genome

In May 2016, Roche received U.S. FDA approval for its cytomegalovirus (CMV) test used in recipients of hematopoietic stem cells transplantation

Cytomegalovirus Diagnostics Market

MARKET SUMMARY

Study Period– 2022 – 2028
Base Year– 2021
CAGR– x%
Largest Market– Asia-Pacific
Fastest Growing Market– North America

Cytomegalovirus Diagnostics Market

The report on global cytomegalovirus diagnostics market gives historical, current and future market sizes (US$ Mn) based on test, application, end-user and region.
cytomegalovirus diagnostics market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.

Key Players

Cell Medical Ltd.
Merck & Co. Inc.
Chimerix, Inc.
Abbott Laboratories
Affymetrix, Inc.

Cytomegalovirus Diagnostics Market

Drivers And Restraints

Rise in diagnosis of CMV cases propelling the growth of global cytomegalovirus diagnosis market. According to Public Health Agency of Canada, 40%-100% of global population are having CMV antibody in the body. Patients with HIV and who has undergone organ transplantation, new-borns, and premature infants are having high risk of CMV infection. As per Centres for Disease Control and Prevention 1 per 150 infants are born with CMV infection in U.S. but only 1 in 5 infants are infected with CMV are having long term health issues.

North-America got significant share

Cytomegalovirus Diagnostics Market

Geographically cytomegalovirus diagnostics market is segmented as Latin America, North America, Asia- Pacific, Europe and The Middle East & Africa. Growing awareness about the herpes virus and rise in diagnosis of CMV cases in the developed regions such as Europe and North America are dominating the market. Initiatives taken by government about the awareness of the CMV disease, rise in healthcare expenditure and increase in disposable income are the few factors propelling market growth in Asia-Pacific region.

Latin-America

North-America

Europe

Asia-Pacific

Middle East

Key

Notable Market Developments

Key

Report Outline

Cytomegalovirus Diagnostics Market Segmentation

By Type

Serology
Cell culture
Antigenemia assay
Polymerase Chain Reaction Amplification
Immunohistochemistry
Nucleic acid sequence-based amplification (NASBA)
Hybrid capture assay

By Application

Retinitis
Pneumonia
Gastrointestinal Ulcers
Encephalitis
Others (Mouth Ulcers, Pharyngitis, etc.)

By End User

Hospitals
Diagnostic Centers
Others

Location

GEOGRAPHY

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

Report

Table Of Content

1. Executive Summary
2. Global Cytomegalovirus Diagnostics Market Introduction
2.1. Global Cytomegalovirus Diagnostics Market – Taxonomy
2.2. Global Cytomegalovirus Diagnostics Market –Definitions
2.2.1. Test Type
2.2.2. End User
3. Global Cytomegalovirus Diagnostics Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Cytomegalovirus Diagnostics Market Dynamic Factors – Impact Analysis
4. Global Cytomegalovirus Diagnostics Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Cytomegalovirus Diagnostics Market, By Test Type, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.1. Serology
5.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Cell Culture
5.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Antigenemia Assay
5.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Polymerase Chain Reaction Amplification
5.4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. Immunohistochemistry
5.5.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
5.6. Nucleic Acid Sequence-based Amplification (NASBA)
5.6.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.6.3. Market Opportunity Analysis
5.7. Hybrid Capture Assay
5.7.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.7.3. Market Opportunity Analysis
6. Global Cytomegalovirus Diagnostics Market, By Application, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
6.1. Retinitis
6.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Pneumonia
6.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Gastroenteritis
6.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Encephalitis
6.4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Others (Mouth Ulcers, Pharyngitis, etc.)
6.5.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
7. Global Cytomegalovirus Diagnostics Market, By End User, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.1. Hospitals
7.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Diagnostic Centers
7.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Others
7.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
8. Global Cytomegalovirus Diagnostics Market Forecast, By Region, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
8.1. North America
8.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Europe
8.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Asia-Pacific
8.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Latin America
8.4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. Middle East and Africa
8.5.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
8.6. Global Cytomegalovirus Diagnostics Market – Opportunity Analysis Index, By Test Type, By Application, By End User, and Region, 2018 – 2024
9. North America Cytomegalovirus Diagnostics Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
9.1. Test Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1. Serology
9.1.2. Cell culture
9.1.3. Antigenemia assay
9.1.4. Polymerase Chain Reaction Amplification
9.1.5. Immunohistochemistry
9.1.6. Nucleic acid sequence-based amplification (NASBA)
9.1.7. Hybrid capture assay
9.2. Application Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.2.1. Retinitis
9.2.2. Pneumonia
9.2.3. Gastrointestinal Ulcers
9.2.4. Encephalitis
9.2.5. Others (Mouth Ulcers, Pharyngitis, etc.)
9.3. End User Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.3.1. Hospitals
9.3.2. Diagnostic Centers
9.3.3. Others
9.4. Country Analysis 2016 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.4.1. U.S.
9.4.2. Canada
9.5. North America Cytomegalovirus Diagnostics Market – Opportunity Analysis Index, By Test Type, By Application, By End User, and Country, 2018 – 2024
9.6. North America Cytomegalovirus Diagnostics Market Dynamics – Trends
10. Europe Cytomegalovirus Diagnostics Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
10.1. Test Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Serology
10.1.2. Cell culture
10.1.3. Antigenemia assay
10.1.4. Polymerase Chain Reaction Amplification
10.1.5. Immunohistochemistry
10.1.6. Nucleic acid sequence-based amplification (NASBA)
10.1.7. Hybrid capture assay
10.2. Application Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.2.1. Retinitis
10.2.2. Pneumonia
10.2.3. Gastrointestinal Ulcers
10.2.4. Encephalitis
10.2.5. Others (Mouth Ulcers, Pharyngitis, etc.)
10.3. End User Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.3.1. Hospitals
10.3.2. Diagnostic Centers
10.3.3. Others
10.4. Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.4.1. Germany
10.4.2. UK
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Russia
10.4.7. Poland
10.4.8. Rest of Europe
10.5. Europe Cytomegalovirus Diagnostics Market – Opportunity Analysis Index, By Test Type, By Application, By End User, and Country, 2018 – 2024
10.6. Europe Cytomegalovirus Diagnostics Market Dynamics – Trends
11. Asia-Pacific Cytomegalovirus Diagnostics Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
11.1. Test Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Serology
11.1.2. Cell culture
11.1.3. Antigenemia assay
11.1.4. Polymerase Chain Reaction Amplification
11.1.5. Immunohistochemistry
11.1.6. Nucleic acid sequence-based amplification (NASBA)
11.1.7. Hybrid capture assay
11.2. Application Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.2.1. Retinitis
11.2.2. Pneumonia
11.2.3. Gastrointestinal Ulcers
11.2.4. Encephalitis
11.2.5. Others (Mouth Ulcers, Pharyngitis, etc.)
11.3. End User Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.3.1. Hospitals
11.3.2. Diagnostic Centers
11.3.3. Others
11.4. Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.4.1. Japan
11.4.2. China
11.4.3. India
11.4.4. ASEAN
11.4.5. Australia & New Zealand
11.4.6. Rest of Asia-Pacific
11.5. Asia-Pacific Cytomegalovirus Diagnostics Market – Opportunity Analysis Index, By Test Type, By Application, By End User, and Country, 2018 – 2024
11.6. Asia-Pacific Cytomegalovirus Diagnostics Market Dynamics – Trends
12. Latin America Cytomegalovirus Diagnostics Market Analysis, 2012 – 2012 – 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
12.1. Test Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Serology
12.1.2. Cell culture
12.1.3. Antigenemia assay
12.1.4. Polymerase Chain Reaction Amplification
12.1.5. Immunohistochemistry
12.1.6. Nucleic acid sequence-based amplification (NASBA)
12.1.7. Hybrid capture assay
12.2. Application Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.2.1. Retinitis
12.2.2. Pneumonia
12.2.3. Gastrointestinal Ulcers
12.2.4. Encephalitis
12.2.5. Others (Mouth Ulcers, Pharyngitis, etc.)
12.3. End User Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.3.1. Hospitals
12.3.2. Diagnostic Centers
12.3.3. Others
12.4. Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Argentina
12.4.4. Venezuela
12.4.5. Rest of Latin America
12.5. Latin America Cytomegalovirus Diagnostics Market – Opportunity Analysis Index, By Test Type, By Application, By End User, and Country, 2018 – 2024
12.6. Latin America Cytomegalovirus Diagnostics Market Dynamics – Trends
13. Middle East and Africa Cytomegalovirus Diagnostics Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
13.1. Test Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Serology
13.1.2. Cell culture
13.1.3. Antigenemia assay
13.1.4. Polymerase Chain Reaction Amplification
13.1.5. Immunohistochemistry
13.1.6. Nucleic acid sequence-based amplification (NASBA)
13.1.7. Hybrid capture assay
13.2. Application Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.2.1. Retinitis
13.2.2. Pneumonia
13.2.3. Gastrointestinal Ulcers
13.2.4. Encephalitis
13.2.5. Others (Mouth Ulcers, Pharyngitis, etc.)
13.3. End User Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.3.1. Hospitals
13.3.2. Diagnostic Centers
13.3.3. Others
13.4. Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.4.1. Gulf Cooperation Council (GCC) Countries
13.4.2. Israel
13.4.3. South Africa
13.4.4. Rest of MEA
13.5. MEA Cytomegalovirus Diagnostics Market – Opportunity Analysis Index, By Test Type, By Application, By End User, and Country, 2018 – 2024
13.6. MEA Cytomegalovirus Diagnostics Market Dynamics – Trends
14. Competition Landscape
14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
14.2.1. Cell Medical Ltd. (U.K.)
14.2.2. Merck & Co. Inc. (U.S.)
14.2.3. Chimerix, Inc. (U.S.)
14.2.4. Abbott Laboratories (U.S.)
14.2.5. Affymetrix, Inc. (U.S.)
14.2.6. Becton, Dickinson and Company (U.S.)
14.2.7. Bio-Rad Laboratories, Inc. (U.S.)
14.2.8. F. Hoffmann-La Roche Ltd.( Switzerland)
14.2.9. Johnson and Johnson Services Inc.,(U.S.)
15. Research Methodology
16. Key Assumptions and Acronyms

Description

Description

Key Developments:

In Jun 2017, Abbott received U.S. FDA approval for Real-time CMV molecular test, the only cytomegalovirus test which is available commercially which amplifies two selective regions of CMV genome

In May 2016, Roche received U.S. FDA approval for its cytomegalovirus (CMV) test used in recipients of hematopoietic stem cells transplantation

search

Cytomegalovirus Diagnostics Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017 to 2021 and Forecast 2022 to 2028

Description

Cytomegalovirus Diagnostics Market

Drivers And Restraints

Cytomegalovirus Diagnostics Market

Notable Market Developments

Report Outline

By Type

By Application

By End User

GEOGRAPHY

Frequently Asked Questions

Table Of Content

Company Profile

Description

Product categories

Our Clients

ASIA PACIFIC OFFICE

EUROPE OFFICE